Dunyan Yao

Mr. Dunyan Yao

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Austin GanawayAustin Ganaway
Austin Ganaway
AKAiri Kamata
Airi Kamata
DYDunyan Yao
Dunyan Yao
KSKazuto Sakoori
Kazuto Sakoori
RORyoma Okada
Ryoma Okada
Metin AkayMetin Akay
Metin Akay
The neurobiology of chronic pain is complex and multifaceted, intertwining with the mesocorticolimbic system to regulate the behavioral and perceptional response to adverse stimuli. Specifically, the ventral tegmental area (VTA), the dopaminergic hub of the reward pathways located deep within the midbrain, is crucial for regulating the release of dopamine (DA) throughout the central nervous system (CNS). To better understand the nuances among chronic pain, VTA response, and therapeutics, implementing progressive approaches for mapping and visualizing the deep brain in real time during nociceptive stimulation is crucial. In this study, we utilize a fluorescence imaging platform with a genetically encoded calcium indicator (GCaMP6s) to directly visualize activity in the VTA during acute nociceptive stimulation in both healthy adult mice and adult mice with partial nerve ligation (PNL)-induced neuropathic pain. We also investigate the visualization of the analgesic properties of morphine. Deep brain imaging using our self-fabricated µ-complementary metal–oxide–semiconductor (CMOS) imaging device allows the tracking of the VTA’s response to adverse stimuli. Our findings show that nociceptive stimulation is associated with a reduction in VTA fluorescence activity, supporting the potential of this platform for visualizing pain-related responses in the central nervous system. Additionally, treatment with morphine significantly reduces the neuronal response caused by mechanical stimuli and is observable using the CMOS imaging platform, demonstrating a novel way to potentially assess and treat neuropathic pain.

3 November 2025 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
DYDunyan Yao
Dunyan Yao
DLDavid A. Lloyd
David A. Lloyd
Metin AkayMetin Akay
Metin Akay
MOMasahiro Ohsawa
Masahiro Ohsawa
Metin AkayMetin Akay
Metin Akay
Chronic pain is a widespread phenomenon affecting over 21% of the United States population. Despite the significant impact of pain on a patient's quality of life, the detection and identification of pain relies on subjective methods such as self-reporting. To address the challenges in identifying and treating chronic pain, a quantifiable biomarker for pain is needed. Here we present novel AI-driven method for the identification and isolation of localized pain signals in the brain during both acute and chronic pain. By using Matching Pursuit (MP) to decompose Local Field Potential (LFP) recordings from the Anterior Cingulate Cortex, the Nucleus Accumbens, and the Prelimbic Cortex, we can learn a latent representation with a conditional variational autoencoder (CVAE) and track changes in latent signal components in response to acute, sub-chronic, and chronic pain after injury. This method allows for both the identification of LFP signal components which are the primary drivers of observed aggregate changes in brain activity during pain, as well as for the tracking of said components over time. The model achieves an average per-feature RMSE of 0.130 on validation data and produces functionally separable latent representations of input MP atoms. The combination of MP for feature extraction and CVAE for latent space development allows for the extraction of both generalized and subject-specific pain motifs involved in chronic pain. These AI-driven biomarkers provide a basis for precision identification and quantitative monitoring of pain over time.